United States · Biotechnology startup
United States · Rubedo Life Sciences
Rubedo Life Sciences is a clinical-stage biopharmaceutical company based in Sunnyvale, California, with a European presence in Milan, Italy.
Funding reportedLast round: Series A
About Rubedo Life Sciences
Rubedo Life Sciences is a clinical-stage biopharmaceutical company based in Sunnyvale, California, with a European presence in Milan, Italy.
Founded in 2018, the company focuses on discovering and developing innovative therapeutics that target senescent cells and other contributors to aging and chronic diseases. Its mission is to extend human healthspan and lifespan by eliminating the cellular drivers of age-related pathologies. The company utilizes its proprietary ALEMBICTM drug discovery platform, which employs AI and machine learning to identify druggable targets associated with senescent cells. Rubedo is developing selective cellular rejuvenation medicines, including its lead candidate RLS-1496, a GPX4 modulator aimed at treating conditions such as plaque psoriasis and idiopathic pulmonary fibrosis. Rubedo is actively engaged in clinical trials to validate the safety and efficacy of its therapies, with plans for further development in neurodegenerative and metabolic disorders.
What company datasets say Rubedo Life Sciences raised
Funding, as reported
Founders and team
From Rubedo Life Sciences's own website: 2 on the team.
- Alex LaslavicChief Technology Officer
- Machine LearningAssociate Professor of Molecular
AdvisersJohn Harris
On 9 portfolio pages
Investors who name them
The Longevity Fund
Beiersdorf
Modi Ventures
B-Engine
Moonstone VC
LongeVC
Evolution VC
IKJ Capital
CDP Venture Capital
Each firm lists Rubedo Life Sciences on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
health caresenescence targetingcellular rejuvenationtranslational researchbiological youthdisease modificationcell therapylongevity medicinecell targetingsingle-cell omicsbiogerontologychemoinformaticshospital & health carebiomedical innovationmedicaltarget validation
Built with from their website
Google WorkspaceGoogle MeetMistReactAlembico EMRVisioWixMicrosoft 365Gmail
- Sector
- Biotechnology
- Industry code
- NAICS 541714, 32541, SIC 2834, 8731
- Region
- California
- Revenue
- $4.5M a year, as listed
- Full record
- Every detail in the company directory
Biotechnology in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Rubedo Life Sciences in front of investors. Or tell us what we have wrong.